These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22546683)

  • 1. Minimizing acylation of peptides in PLGA microspheres.
    Zhang Y; Schwendeman SP
    J Control Release; 2012 Aug; 162(1):119-26. PubMed ID: 22546683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new class of inhibitors of peptide sorption and acylation in PLGA.
    Sophocleous AM; Zhang Y; Schwendeman SP
    J Control Release; 2009 Aug; 137(3):179-84. PubMed ID: 19318114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of peptide acylation in PLGA microspheres with water-soluble divalent cationic salts.
    Zhang Y; Sophocleous AM; Schwendeman SP
    Pharm Res; 2009 Aug; 26(8):1986-94. PubMed ID: 19533307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring of peptide acylation inside degrading PLGA microspheres by capillary electrophoresis and MALDI-TOF mass spectrometry.
    Na DH; Youn YS; Lee SD; Son MW; Kim WB; DeLuca PP; Lee KC
    J Control Release; 2003 Oct; 92(3):291-9. PubMed ID: 14568410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide acylation by poly(alpha-hydroxy esters).
    Lucke A; Kiermaier J; Göpferich A
    Pharm Res; 2002 Feb; 19(2):175-81. PubMed ID: 11883645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microcosmic mechanism of dication for inhibiting acylation of acidic Peptide.
    Qi F; Yang L; Wu J; Ma G; Su Z
    Pharm Res; 2015 Jul; 32(7):2310-7. PubMed ID: 25585955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical-Chemical Characterization of Octreotide Encapsulated in Commercial Glucose-Star PLGA Microspheres.
    Beig A; Feng L; Walker J; Ackermann R; Hong JKY; Li T; Wang Y; Qin B; Schwendeman SP
    Mol Pharm; 2020 Nov; 17(11):4141-4151. PubMed ID: 32876463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled release of octreotide and assessment of peptide acylation from poly(D,L-lactide-co-hydroxymethyl glycolide) compared to PLGA microspheres.
    Ghassemi AH; van Steenbergen MJ; Barendregt A; Talsma H; Kok RJ; van Nostrum CF; Crommelin DJ; Hennink WE
    Pharm Res; 2012 Jan; 29(1):110-20. PubMed ID: 21744173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Octreotide Acylation Inside PLGA Microspheres by Derivatization of the Amines of the Peptide with a Self-Immolative Protecting Group.
    Shirangi M; Najafi M; Rijkers DT; Kok RJ; Hennink WE; van Nostrum CF
    Bioconjug Chem; 2016 Mar; 27(3):576-85. PubMed ID: 26726953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of chemically modified peptide from poly(D,L-lactide-co-glycolide) microspheres under in vitro release conditions.
    Murty SB; Goodman J; Thanoo BC; DeLuca PP
    AAPS PharmSciTech; 2003 Oct; 4(4):E50. PubMed ID: 15198545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton Oriented-"Smart Depot" for Responsive Release of Ca
    Liu J; Xu Y; Wang Y; Ren H; Meng Z; Liu K; Liu Z; Huang H; Li X
    Pharm Res; 2019 Jun; 36(8):119. PubMed ID: 31165279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PEGylation of octreotide: I. Separation of positional isomers and stability against acylation by poly(D,L-lactide-co-glycolide).
    Na DH; DeLuca PP
    Pharm Res; 2005 May; 22(5):736-42. PubMed ID: 15906168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimizing the initial burst of octreotide acetate from glucose star PLGA microspheres prepared by the solvent evaporation method.
    Beig A; Ackermann R; Wang Y; Schutzman R; Schwendeman SP
    Int J Pharm; 2022 Aug; 624():121842. PubMed ID: 35609832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation, characterization, and in vivo evaluation of salmon calcitonin microspheres.
    Dani BA; DeLuca PP
    AAPS PharmSciTech; 2001 Oct; 2(4):22. PubMed ID: 14727859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acylation of peptides by lactic acid solutions.
    Lucke A; Göpferich A
    Eur J Pharm Biopharm; 2003 Jan; 55(1):27-33. PubMed ID: 12551701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impurity formation studies with peptide-loaded polymeric microspheres Part II. In vitro evaluation.
    Murty SB; Na DH; Thanoo BC; DeLuca PP
    Int J Pharm; 2005 Jun; 297(1-2):62-72. PubMed ID: 15885939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and characterization of composition-equivalent formulations to the Sandostatin LAR® by the solvent evaporation method.
    Beig A; Feng L; Walker J; Ackermann R; Hong JKY; Li T; Wang Y; Schwendeman SP
    Drug Deliv Transl Res; 2022 Mar; 12(3):695-707. PubMed ID: 34215997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and Assessment of Octreotide Acylation in Polyester Microspheres by LC-MS/MS.
    Shirangi M; Hennink WE; Somsen GW; van Nostrum CF
    Pharm Res; 2015 Sep; 32(9):3044-54. PubMed ID: 25832500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of PEGylated exendin-4 released from poly (lactic-co-glycolic acid) microspheres for antidiabetic therapy.
    Lim SM; Eom HN; Jiang HH; Sohn M; Lee KC
    J Pharm Sci; 2015 Jan; 104(1):72-80. PubMed ID: 25407390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of excipients on PLGA film degradation and the stability of an incorporated peptide.
    Houchin ML; Neuenswander SA; Topp EM
    J Control Release; 2007 Feb; 117(3):413-20. PubMed ID: 17207882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.